Please login to the form below

Not currently logged in
Email:
Password:

drug delivery

This page shows the latest drug delivery news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Last year the Italian firm paid $300m to purchase AstraZeneca’s European rights to cardiovascular drug Seloken and related combination Logimax. ... LIQ861 is in phase III trials to improve the therapeutic profile of off-patent drug treprostinil by

Latest news

More from news
Approximately 3 fully matching, plus 190 partially matching documents found.

Latest Intelligence

  • The true potential of mobile health tech The true potential of mobile health tech

    If it works, we will get better drug delivery, improved adherence, more committed patients and a reduction of waste.

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    2. Improve understanding of complex treatments. Unprecedented scientific discovery has led to an increased focus on developing specialised treatments that are highly complex - both in action and in delivery. ... Think of the value of virtually

  • A new era of smart pharma A new era of smart pharma

    Blending Reportum with AI and Robotic tools affords pharma companies the opportunity to transform their end-to-end drug safety processes today. ... Medical adherence is being improved. Drug delivery technology has improved significantly in recent years.

  • A quest for innovative solutions A quest for innovative solutions

    to more than 300 with the creation of PRISM (Patient Relevant Innovative Solutions Mission) which seeks out the nuggets of therapeutic value and delivery innovation. ... Technology’s attractive calling card is the monitoring and collection of data that

  • Breakthrough innovation Breakthrough innovation

    Many pharmaceutical companies are increasingly looking to innovate through the development of companion diagnostics and drug delivery devices, and/or services such as patient monitoring and adherence support. ... Case study: developing a breakthrough

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Philips promotes Simon McGuire to health systems lead Philips promotes Simon McGuire to health systems lead

    Philips promotes Simon McGuire to health systems lead. He was previously GM at Philips Respironics Respiratory Drug Delivery. ... McGuire was previously Philips' general manager of respiratory drug delivery in sleep and respiratory care, having joined

  • Albumedix appoints Dr Giles Campion as CMO Albumedix appoints Dr Giles Campion as CMO

    Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform. ... He brings over 25 years of drug development experience to the role, most recently as group vice president

  • Catalent appoints two board members Catalent appoints two board members

    Catalent appoints two board members. Jack Stahl and Rolf Classon to advise drug development, delivery and supply company. ... Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their

  • MedImmune appoints Dr Anand Subramony MedImmune appoints Dr Anand Subramony

    MedImmune appoints Dr Anand Subramony. He joins from Novartis to take up drug delivery and device development role. ... AstraZeneca's MedImmune unit has appointed Dr Anand Subramony as its new vice president of drug delivery and device development.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Patient Centricity: Turning Rhetoric into Reality

    However is this transformation working? A patient-centric model demands huge investment and a company-wide commitment to putting patient wants and needs first during all stages of healthcare delivery, from ... drug discovery through to long-term disease

  • Catalent Pharma Solutions

    Catalent Pharma Solutions. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics